Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lee, Helen S.
Plechot, Kamryn
Gohil, Shruti
and
Le, Jennifer
2021.
Clostridium difficile: Diagnosis and the Consequence of Over Diagnosis.
Infectious Diseases and Therapy,
Vol. 10,
Issue. 2,
p.
687.
Bogdanová, Kateřina
Doubravská, Lenka
Vágnerová, Iva
Hricová, Kristýna
Pudová, Vendula
Röderová, Magdaléna
Papajk, Jan
Uvízl, Radovan
Langová, Kateřina
and
Kolář, Milan
2021.
Clostridioides difficile and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia.
Life,
Vol. 11,
Issue. 11,
p.
1127.
Kelly, Colleen R.
Fischer, Monika
Allegretti, Jessica R.
LaPlante, Kerry
Stewart, David B.
Limketkai, Berkeley N.
and
Stollman, Neil H.
2021.
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.
American Journal of Gastroenterology,
Vol. 116,
Issue. 6,
p.
1124.
Poylin, Vitaliy
Hawkins, Alexander T.
Bhama, Anuradha R.
Boutros, Marylise
Lightner, Amy L.
Khanna, Sahil
Paquette, Ian M.
and
Feingold, Daniel L.
2021.
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Clostridioides difficile Infection.
Diseases of the Colon & Rectum,
Vol. 64,
Issue. 6,
p.
650.
2021.
Oral Vancomycin Prophylaxis for Clostridioides difficile
.
AAP Grand Rounds,
Vol. 46,
Issue. 5,
p.
56.
Correa-Martínez, Carlos L.
Hagemeier, Niklas C. J.
Froböse, Neele J.
and
Kampmeier, Stefanie
2021.
Impact of Clostridioides difficile Therapy on Nosocomial Acquisition of Vancomycin-Resistant Enterococci.
Pharmaceuticals,
Vol. 14,
Issue. 11,
p.
1066.
Tariq, Raseen
Laguio-Vila, Maryrose
Tahir, Muhammad Waqas
Orenstein, Robert
Pardi, Darrell S.
and
Khanna, Sahil
2021.
Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis.
Therapeutic Advances in Gastroenterology,
Vol. 14,
Issue. ,
p.
175628482199404.
Tytgat, N. J.
2021.
Meeting report of Gastro Update Europe 2020, September 4-5, 2020.
Experimental and Clinical Gastroenterology,
p.
120.
Reigadas, Elena
van Prehn, Joffrey
Falcone, Marco
Fitzpatrick, Fidelma
Vehreschild, Maria J.G.T.
Kuijper, Ed J.
and
Bouza, Emilio
2021.
How to: prophylactic interventions for prevention of Clostridioides difficile infection.
Clinical Microbiology and Infection,
Vol. 27,
Issue. 12,
p.
1777.
Sacks, Chana A.
and
Berger, Rebecca E.
2022.
Does Prophylaxis Prevent Recurrent
Clostridioides difficile
Infection?
.
NEJM Evidence,
Vol. 1,
Issue. 4,
Maraolo, Alberto Enrico
Mazzitelli, Maria
Zappulo, Emanuela
Scotto, Riccardo
Granata, Guido
Andini, Roberto
Durante-Mangoni, Emanuele
Petrosillo, Nicola
and
Gentile, Ivan
2022.
Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis.
Antibiotics,
Vol. 11,
Issue. 2,
p.
183.
Büchler, Andrea C.
and
Voor in ‘t holt, Anne F.
2023.
Assessing the methodological quality of studies included in systematic reviews: Interpretation of scores.
Infection Control & Hospital Epidemiology,
Vol. 44,
Issue. 1,
p.
169.
KAMIYA, Shigeru
2023.
Microbial ecology between <i>Clostridioides difficile</i> and gut microbiota.
Bioscience of Microbiota, Food and Health,
Vol. 42,
Issue. 4,
p.
229.
Chang, Leslie L.
Allegretti, Jessica
Skinner, Andrew M.
and
Dubberke, Erik R.
2023.
Oral Vancomycin as Secondary Prophylaxis for Prevention of Recurrent
Clostridioides difficile
Infection
.
New England Journal of Medicine,
Vol. 388,
Issue. 7,
p.
654.
Ivashkin, V. T.
Maev, I. V.
Andreev, D. N.
Goloshchapov, O. V.
Derinov, A. A.
Zolnikova, O. Yu.
Ivashkin, K. V.
Kiseleva, O. Yu.
Kiryukhin, A. P.
Lyashenko, O. S.
Poluektova, E. A.
Tertychnyy, A. S.
Trukhmanov, A. S.
Ulyanin, A. I.
Sheptulin, A. A.
and
Shifrin, O. S.
2023.
Modern Approaches to the Diagnosis and treatment of <i>Clostridioides difficile (C. difficile)</i>-associated Disease in Adults (literature Review and Expert Council Resolution).
Russian Journal of Gastroenterology, Hepatology, Coloproctology,
Vol. 33,
Issue. 2,
p.
19.
Yu, Kalvin C.
Ye, Gang
Edwards, Jonathan R.
Dantes, Raymund
Gupta, Vikas
Ai, ChinEn
Betz, Kristina
and
Benin, Andrea L.
2024.
Treated, hospital-onset Clostridiodes difficile infection: An evaluation of predictors and feasibility of benchmarking comparing 2 risk-adjusted models among 265 hospitals.
Infection Control & Hospital Epidemiology,
Vol. 45,
Issue. 1,
p.
48.
Clarke, Lindsay M.
and
Allegretti, Jessica R.
2024.
Review article: The epidemiology and management of Clostridioides difficile infection—A clinical update.
Alimentary Pharmacology & Therapeutics,
Vol. 59,
Issue. 11,
p.
1335.
Di Bella, Stefano
Sanson, Gianfranco
Monticelli, Jacopo
Zerbato, Verena
Principe, Luigi
Giuffrè, Mauro
Pipitone, Giuseppe
Luzzati, Roberto
Staley, Christopher
and
Abhyankar, Mayuresh
2024.
Clostridioides difficile
infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options
.
Clinical Microbiology Reviews,
Vol. 37,
Issue. 2,
Manthey, Carolin F.
Epple, Hans-Jörg
Keller, Klaus-Michael
Lübbert, Christoph
Posovszky, Carsten
Ramharter, Michael
Reuken, Philipp
Suerbaum, Sebastian
Vehreschild, Maria
Weinke, Thomas
Addo, Marylyn M.
Stallmach, Andreas
and
Lohse, Ansgar W.
2024.
S2k-Leitlinie Gastrointestinale Infektionen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).
Zeitschrift für Gastroenterologie,
Vol. 62,
Issue. 07,
p.
1090.
Najjar-Debbiny, Ronza
Barnett-Griness, Ofra
Arbel, Anat
Cohen, Shai
Weber, Gabriel
Amar, Maisam
Yassin, Rabah
Greenfeld, Inbal
Shehadeh, Shereen
and
Saliba, Walid
2024.
Secondary prophylaxis for Clostridioides difficile infection for patients on non-C. difficile antibiotics: a retrospective cohort study.
Microbes and Infection,
Vol. 26,
Issue. 5-6,
p.
105349.